Some people find that their energy fluctuates during dose titration, stabilizing once they reach their maintenance dose
A 2021 review published in Nutrients found that GLP-1 receptor agonist use was associated with reduced dietary intake of multiple micronutrients including B12, particularly in patients following calorie-restricted eating patterns, supporting the rationale for monitoring B12 status during treatment even in patients without pre-existing deficiency risk factors
Reviewed by Paul Holmes Director of Science and Innovation at Naturecan Testing for large pharmaceutical & tobacco companies, Paul has built a wealth of scientific and regulatory knowledge, working on regulatory submissions to bodies such as the FDA and the MHRA
The KLOW Blend is intended for research use only and is not for human or animal therapeutic applications
They will mention bloating and gas briefly, then pivot immediately to benefits and a purchase link
They can adjust the dosage based on the individual's response and ensure safe administration